Theravance Biopharma (TBPH) Return on Capital Employed Growth (1y) (2015 - 2026)
Theravance Biopharma (TBPH) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
16,829.00 |
| 10 |
Theravance Biopharma |
846.10 Mn |
451.44 Mn |
- |
1,611.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,611.00 |
| Dec 31, 2025 |
1,366.00 |
| Sep 30, 2025 |
455.00 |
| Jun 30, 2025 |
93.00 |
| Mar 31, 2025 |
-389.00 |
| Dec 31, 2024 |
49.00 |
| Sep 30, 2024 |
350.00 |
| Jun 30, 2024 |
225.00 |
| Mar 31, 2024 |
241.00 |
| Dec 31, 2023 |
-102.00 |
| Sep 30, 2023 |
1,451.00 |
| Jun 30, 2023 |
3,938.00 |
| Mar 31, 2023 |
5,186.00 |
| Dec 31, 2022 |
6,403.00 |
| Sep 30, 2022 |
4,832.00 |
| Jun 30, 2022 |
3,604.00 |
| Mar 31, 2022 |
2,594.00 |
| Dec 31, 2021 |
309.00 |
| Sep 30, 2021 |
-1,219.00 |
| Jun 30, 2021 |
-3,124.00 |
